Frontlight ResearchEarly access
Trial site
Rare Disease Research, LLC
- 9running trials
- 6closed trials
The trials here
What the 15 trials at this site are about, from their registry records.
- Conditions
- Duchenne muscular dystrophy5 trials
- Migraine2 trials
- Mitochondrial disease2 trials
- Spinal muscular atrophy2 trials
- Tourette syndrome2 trials
- Epilepsy1 trial
- Myotonic dystrophy1 trial
- Phase
- Phase 310 trials
- Phase 1/22 trials
- Phase 22 trials
- Phase 41 trial
- Status
- Active, not recruiting7 trials
- Completed4 trials
- Recruiting2 trials
- Terminated2 trials
- Lead sponsor
- Dyne Therapeutics2 trials
- Emalex Biosciences Inc.2 trials
- Pfizer2 trials
- Biogen1 trial
- Capricor Inc.1 trial
- and 7 more
Running trials
Recruiting
Active, not recruiting
Recruiting
Efficacy of KL1333 in Adult Patients With Primary Mitochondrial Disease
Active, not recruiting
Active, not recruiting
Active, not recruiting
Active, not recruiting
Open-label Study of WVE-N531 in Patients With Duchenne Muscular Dystrophy (FORWARD-53)
Recruiting
Long-term Safety Study of Rimegepant in Pediatric Subjects for the Acute Treatment of Migraine
Recruiting
Randomized Study in Children and Adolescents With Migraine: Acute Treatment
Recruiting at the same time
How many trials recruit for the same indication here at once. A count, not a rating.
- Mitochondrial disease1 recruiting
- Myotonic dystrophy1 recruiting
Closed trials
Site data: ClinicalTrials.govUpdated 15 Nov 2026